Aligos Therapeutics (ALGS) Stock Chart & Stock Price History → What President Biden's new law means for investors (From Stansberry Research) (Ad) Free ALGS Stock Alerts $0.66 -0.01 (-1.65%) (As of 02:03 PM ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Aligos Therapeutics Stock Price Performance5 Day Performance+0.76%1 Month Performance-12.00%3 Month Performance-0.90%6 Month Performance+1.23%Year-To-Date Performance-0.60%1 Year Performance-35.92% Receive ALGS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad StocksToTradeWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.Discover the #1 company leading this revolution ALGS Stock Chart for Tuesday, May, 21, 2024 ALGS Chart by TradingView Aligos Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/20/2024$0.69$0.67-2.53%$0.72$0.66158,481 shs$52.42 million05/17/2024$0.66$0.69+5.11%$0.75$0.66884,254 shs$52.10 million05/16/2024$0.68$0.66-3.55%$0.70$0.65108,855 shs$49.56 million05/15/2024$0.69$0.68-1.79%$0.71$0.6791,156 shs$51.39 million05/14/2024$0.68$0.69+1.01%$0.72$0.67191,033 shs$52.33 million05/13/2024$0.73$0.68-6.26%$0.74$0.67248,404 shs$51.80 million Get the Latest News and Ratings for ALGS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/10/2024$0.78$0.73-5.95%$0.78$0.72184,447 shs$55.26 million05/09/2024$0.78$0.78-0.86%$0.79$0.76145,640 shs$58.76 million05/08/2024$0.79$0.78-0.86%$0.82$0.77162,865 shs$59.27 million05/07/2024$0.81$0.79-2.47%$0.84$0.79127,120 shs$59.78 million05/06/2024$0.81$0.81-0.01%$0.83$0.80154,828 shs$61.29 million05/03/2024$0.85$0.81-4.24%$0.85$0.78185,331 shs$61.30 million05/02/2024$0.77$0.85+9.87%$0.87$0.75326,243 shs$64.02 million05/01/2024$0.77$0.77+0.65%$0.79$0.7584,256 shs$58.27 million04/30/2024$0.73$0.77+4.25%$0.79$0.74181,038 shs$57.89 million04/29/2024$0.78$0.73-6.16%$0.82$0.73137,290 shs$55.53 million04/26/2024$0.82$0.78-4.40%$0.83$0.77110,561 shs$59.17 million04/25/2024$0.83$0.82-1.33%$0.83$0.78132,091 shs$61.90 million04/24/2024$0.82$0.83+0.66%$0.87$0.79644,254 shs$62.73 million04/23/2024$0.80$0.82+2.82%$0.90$0.8096,855 shs$62.32 million04/22/2024$0.75$0.80+6.80%$0.81$0.74469,851 shs$60.61 million04/19/2024$0.79$0.75-5.43%$0.80$0.73141,291 shs$56.75 million04/18/2024$0.79$0.79+0.78%$0.83$0.76239,328 shs$60.01 million04/17/2024$0.84$0.79-5.75%$0.83$0.79124,521 shs$59.55 million04/16/2024$0.89$0.84-6.67%$0.91$0.80247,318 shs$63.18 million04/15/2024$1.00$0.89-10.53%$1.01$0.87329,041 shs$67.70 million04/12/2024$1.06$1.00-5.66%$1.08$1.00293,101 shs$75.67 million04/11/2024$1.04$1.06+1.92%$1.09$1.02356,580 shs$80.21 million04/10/2024$1.06$1.04-1.89%$1.08$0.99347,862 shs$78.70 million04/09/2024$1.07$1.06-0.93%$1.10$1.03237,443 shs$80.21 million04/08/2024$1.04$1.07+2.88%$1.09$1.02336,768 shs$80.97 million04/05/2024$0.97$1.04+6.94%$1.04$0.97291,068 shs$78.70 million04/04/2024$1.01$0.97-3.71%$1.02$0.96356,994 shs$73.59 million04/03/2024$0.98$1.01+3.27%$1.04$0.97407,571 shs$76.43 million04/02/2024$0.95$0.98+2.80%$1.00$0.92324,550 shs$74.01 million04/01/2024$0.98$0.95-2.92%$1.04$0.95668,666 shs$71.99 million03/29/2024$0.98$0.98$1.00$0.92312,472 shs$74.16 million03/28/2024$0.98$0.98+0.10%$1.00$0.92312,472 shs$74.16 million03/27/2024$1.02$0.98-4.02%$1.02$0.94646,619 shs$74.08 million03/26/2024$0.94$1.02+8.66%$1.02$0.90372,962 shs$77.18 millionClaim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now03/25/2024$0.99$0.94-5.18%$1.01$0.93354,177 shs$71.03 million03/22/2024$0.95$0.99+4.21%$0.99$0.92235,516 shs$74.18 million03/21/2024$0.95$0.95-0.31%$0.97$0.92299,061 shs$71.18 million03/20/2024$0.93$0.95+2.30%$0.96$0.90461,568 shs$71.41 million03/19/2024$0.92$0.93+1.26%$0.94$0.91262,244 shs$69.81 million03/18/2024$0.92$0.92-0.16%$0.95$0.90250,878 shs$68.94 million03/15/2024$0.87$0.92+5.96%$0.97$0.841.05 million shs$69.05 million03/14/2024$0.87$0.87-0.03%$0.89$0.78684,253 shs$65.17 million03/13/2024$0.87$0.87$0.96$0.831.29 million shs$65.19 million03/12/2024$0.88$0.87-1.14%$0.90$0.81261,498 shs$65.19 million03/11/2024$0.84$0.88+4.75%$0.88$0.80219,978 shs$65.94 million03/08/2024$0.93$0.84-9.67%$0.93$0.82427,275 shs$62.95 million03/07/2024$0.98$0.93-5.10%$1.05$0.87375,195 shs$69.69 million03/06/2024$1.00$0.98-1.98%$1.06$0.97507,195 shs$73.43 million03/05/2024$0.99$1.00+0.98%$1.01$0.96418,166 shs$74.92 million03/04/2024$1.13$0.99-12.38%$1.20$0.90901,956 shs$74.19 million03/01/2024$0.99$1.13+14.14%$1.15$0.98680,595 shs$84.67 million02/29/2024$0.96$0.99+3.13%$0.99$0.95252,560 shs$74.18 million02/28/2024$0.95$0.96+1.05%$0.98$0.91411,249 shs$71.93 million02/27/2024$0.91$0.95+4.40%$0.99$0.91831,361 shs$71.18 million02/26/2024$0.75$0.91+21.33%$0.95$0.761.35 million shs$68.19 million02/23/2024$0.80$0.75-6.25%$0.83$0.75787,395 shs$56.20 million02/22/2024$0.67$0.80+20.12%$0.85$0.651.66 million shs$59.94 million02/21/2024$0.64$0.67+4.01%$0.70$0.64668,159 shs$49.90 million02/20/2024$0.65$0.64-1.49%$0.71$0.63329,210 shs$47.98 million Related Companies: LENZ Therapeutics Stock Chart AVROBIO Stock Chart Genenta Science Stock Chart IN8bio Stock Chart Cidara Therapeutics Stock Chart Dyadic International Stock Chart OKYO Pharma Stock Chart Cyclo Therapeutics Stock Chart Ikena Oncology Stock Chart Quince Therapeutics Stock Chart Receive ALGS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aligos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALGS) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account Before It’s Too LateWeiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aligos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.